Inhibition of inducible nitric oxide controls pathogen load and brain damage by enhancing phagocytosis of Escherichia coli K1 in neonatal meningitis

American Journal of Pathology

Volumn 176, Issue 3, 2010, Pages 1292-1305

  Mittal, Rahul ^a   Gonzalez Gomez, Ignacio ^a,c   Goth, Kerstin A ^b   Prasadarao, Nemani V ^a,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEREMIA; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERICIDAL ACTIVITY; BRAIN DAMAGE; CONTROLLED STUDY; ENZYME INHIBITION; ESCHERICHIA COLI INFECTION; HISTOPATHOLOGY; INFECTION PREVENTION; MOUSE; NEUTROPHIL; NEWBORN; NEWBORN INFECTION; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 77749237174     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090851     Document Type: Article

References (81)

1. Somand D, Meurer W: Central nervous system infections. Emerg Med Clin North Am 2009, 27:89-100
2. Dawson KG, Emerson JC, Burns JL: Fifteen years of experience with bacterial meningitis. Pediatr Infect Dis J 1999, 18:816-822
3. Sinner SW, Tunkel AR: Antimicrobial agents in the treatment of bacterial meningitis. Infect Dis Clin North Am 2004, 18:581-602
4. Stoll BJ: The global impact of neonatal infection. Clin Perinatol 1997, 24:1-21
5. Tebruegge M, Curtis N: Epidemiology, etiology, pathogenesis, and diagnosis of recurrent bacterial meningitis. Clin Microbiol Rev 2008, 21:519-537
6. Tunkel AR, Scheld WM: Pathogenesis and pathophysiology of bacterial meningitis. Clin Microbiol Rev 1993, 6:118-136
7. Polin RA, Harris MC: Neonatal bacterial meningitis. Semin Neonatol 2001, 6:157-172
8. Scheld WM, Koedel U, Nathan B, Pfister HW: Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury. J Infect Dis 2002, 186:S225-S233
9. Mulder CJ, van Alphen L, Zanen HC: Neonatal meningitis caused by Escherichia coli in the Netherlands. J Infect Dis 1984, 150:935-940
10. de Louvois J, Blackbourn J, Hurley R, Harvey D: Infantile meningitis in England and Wales: a two year study. Arch Dis Child 1991, 66:603-607
11. Houdouin V, Bonacorsi S, Bidet P, Blanco J, De La Rocque F, Cohen R, Aujard Y, Bingen E: Association between mortality of Escherichia coli meningitis in young infants and non-virulent clonal groups of strains. Clin Microbiol Infect 2008, 14:685-690
12. Bonacorsi S, Bingen E: Molecular epidemiology of Escherichia coli causing neonatal meningitis. Int J Med Microbiol 2005, 295:373-381
13. Bizzarro MJ, Dembry LM, Baltimore RS, Gallagher PG: Changing patterns in neonatal Escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis. Pediatrics 2008, 121:689-696
14. Ramdani-Bouguessa N, Mendonça N, Leitao J, Ferreira E, Tazir M, Caniça M: CTX-M-3 and CTX-M-15 extended-spectrum β-lactamases in isolates of Escherichia coli from a hospital in Algiers. Algeria J Clin Microbiol 2006, 44:4584-4586
15. Boyer-Mariotte S, Duboc P, Bonacorsi S, Lemeland JF, Bingen E, Pinquier D: CTX-M-15-producing Escherichia coli in fatal neonatal meningitis: failure of empirical chemotherapy. J Antimicrob Chemother 2008, 62:1472-1474
16. Kim KS: Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury. Nat Rev Neurosci 2003, 4:376-385
17. Suzuki Y, Fujii S, Tominaga T, Yoshimoto T, Fujii S, Akaike T, Maeda H, Yoshimura T: Direct evidence of in vivo nitric oxide production and inducible nitric oxide synthase mRNA expression in the brain of living rat during experimental meningitis. J Cereb Blood Flow Metab 1999, 19:1175-1178
18. Kornelisse RF, Hoekman K, Visser JJ, Hop WC, Huijmans JG, van der Straaten PJ, van der Heijden AJ, Sukhai RN, Neijens HJ, de Groot R: The role of nitric oxide in bacterial meningitis in children. J Infect Dis 1996, 174:120-126
19. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med 1993, 329:2002-2012
20. Stuehr DJ: Mammalian nitric oxide synthases. Biochim Biophys Acta 1999, 1411:217-230
21. Nathan C, Xie QW: Nitric oxide synthases: roles, tolls, and controls. Cell 1994, 78:915-918
22. Lowenstein CJ, Dinerman JL, Snyder SH: Nitric oxide: a physiologic messenger. Ann Intern Med 1994, 120:227-237
23. Nathan C: Nitric oxide as a secretory product of mammalian cells. FASEB J 1992, 6:3051-3064
24. Galea E, Reis DJ, Feinstein DL: Cloning and expression of inducible nitric oxide synthase from rat astrocytes. J Neurosci Res 1994, 37:406-414
25. Nunokawa Y, Ishida N, Tanaka S: Cloning of inducible nitric oxide synthase in rat vascular smooth muscle cells. Biochem Biophys Res Commun 1993, 191:89-94
26. Moncada S, Palmer RM, Higgs EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991, 43:109-142
27. Bogdan C, Rollinghoff M, Diefenbach A: The role of nitric oxide in innate immunity. Immunol Rev 2000, 173:17-26
28. Bogdan C: The multiplex function of nitric oxide in (auto)immunity. J Exp Med 1998, 187:1361-1365
29. Bogdan C, Rollinghoff M, Diefenbach A: Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr Opin Immunol 2000, 12:64-76
30. Fang FC: Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity J Clin Invest 1997, 99:2818-2825
31. Licinio J, Prolo P, McCann SM, Wong ML: Brain iNOS: current understanding and clinical implications. Mol Med Today 1999, 5:225-232
32. Akaike T, Noguchi Y, Ijiri S, Setoguchi K, Suga M, Zheng YM, Dietzschold B, Maeda H: Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc Natl Acad Sci USA 1996, 93:2448-2453
33. Koprowski H, Zheng YM, Heber-Katz E, Fraser N, Rorke L, Fu ZF, Hanlon C, Dietzschold B: In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc Natl Acad Sci USA 1993, 90:3024-3027
34. Koedel U, Bernatowicz A, Paul R, Frei K, Fontana A, Pfister HW: Experimental pneumococcal meningitis: cerebrovascular alterations, brain edema, and meningeal inflammation are linked to the production of nitric oxide. Ann Neurol 1995, 37:313-323
35. Buster BL, Weintrob AC, Townsend GC, Scheld WM: Potential role of nitric bacterial meningitis oxide in the pathophysiology of experimental bacterial meningitis in rats. Infect Immun 1995, 63:3835-3839
36. Mittal R, Prasadarao NV: Nitric oxide/cGMP signaling induces Escherichia coli K1 receptor expression and modulates the permeability in human brain endothelial cell monolayers during invasion. Cell Microbiol 2010, 12:67-83
37. Prasadarao NV, Wass CA, Weiser JN, Stins MF, Huang SH, Kim KS: Outer membrane protein A of Escherichia coli contributes to invasion of brain microvascular endothelial cells. Infect Immun 1996, 64:146-153
38. Mittal R, Wang Y, Hunter CJ, Gonzalez-Gomez I, Prasadarao NV: Brain damage in newborn rat model of meningitis by Enterobacter sakazakii: a role for outer membrane protein A. Lab Invest 2009, 89:263-277
39. Mittal R, Sharma S, Chhibber S, Harjai K: Contribution of free radicals to Pseudomonas aeruginosa induced acute pyelonephritis. Microb Pathog 2008, 45:323-330
40. Lu B, Figini M, Emanueli C, Geppetti P, Grady EF, Gerard NP, Ansell J, Payan DG, Gerard C, Bunnett N: The control of microvascular permeability and blood pressure by neutral endopeptidase. Nat Med 1997, 3:904-907
41. Mittal R, Sharma S, Chhibber S, Harjai K: Iron dictates the virulence of Pseudomonas aeruginosa in urinary tract infections. J Biomed Sci 2008, 15:731-741
42. Luo Y, Dorf ME: Isolation of mouse neutrophils. Curr Protoc Immunol 2001 Chapter 3:Unit 3.20
43. Prasadarao NV, Wass CA, Kim KS: Endothelial cell GlcNAc beta 1-4GlcNAc epitopes for outer membrane protein A enhance traversal of Escherichia coli across the blood-brain barrier. Infect Immun 1996, 64:154-160
44. Durand ML, Calderwood SB, Weber DJ, Miller SI, Southwick FS, Caviness VS Jr, Swartz MN: Acute bacterial meningitis in adults: a review of 493 episodes. N Engl J Med 1993, 328:21-28
45. Kim KS: Escherichia coli translocation of the blood-brain barrier. Infect Immun 2001, 69:5217-5222
46. Paul R, Koedel U, Pfister HW: Development of adjunctive therapies for bacterial meningitis and lessons from knockout mice. Neurocrit Care 2005, 2:313-324
47. Sukumaran SK, Shimada H, Prasadarao NV: Entry and intracellular replication of Escherichia coli K1 in macrophages require expression of outer membrane protein A. Infect Immun 2003, 71:5951-5961
48. Albina JE, Cui S, Mateo RB, Reichner JS: Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol 1993, 150:5080-5085
49. Prasadarao NV: Identification of E. coli outer membrane protein A receptor on human brain microvascular endothelial cells. Infect Immun 2002, 70:4556-4563
50. Yang Y, Liu B, Dai J, Srivastava PK, Zammit DJ, Lefrançois L, Li Z: Heat shock protein gp96 is a master chaperone for toll-like receptors and is important in the innate function of macrophages. Immunity 2007, 26:215-226
51. Isberg RR, O'Connor TJ, Heidtman M: The Legionella pneumophila replication vacuole: making a cosy niche inside host cells. Nat Rev Microbiol 2009, 7:13-24
52. Sansonetti P: Phagocytosis of bacterial pathogens: implications in the host response. Semin Immunol 2001, 13:381-390
53. Hunter CJ, Williams M, Petrosyan M, Guner Y, Mittal R, Mock D, Upperman JS, Ford HR, Prasadarao NV: Lactobacillus bulgaricus prevents intestinal epithelial cell injury caused by Enterobacter sakazakii-induced nitric oxide both in vitro and in the newborn rat model of necrotizing enterocolitis. Infect Immun 2009, 77:1031-1043
54. Murawska-Ciatowicz E, Szychowska Z, Trebusiewicz B: Nitric oxide production during bacterial and viral meningitis in children. Int J Clin Lab Reg 2000, 30:127-131
55. Stevanin TM, Moir JW, Read RC: Nitric oxide detoxification systems enhance survival of Neisseria meningitidis in human macrophages and in nasopharyngeal mucosa. Infect Immun 2005, 73:3322-3329
56. Koedel U, Paul R, Winkler F, Kastenbauer S, Huang PL, Pfister HW: Lack of endothelial nitric oxide synthase aggravates murine pneumococcal meningitis. J Neuropathol Exp Neurol 2001, 60:1041-1050
57. Iovine NM, Pursnani S, Voldman A, Wasserman G, Blaser MJ, Weinrauch Y: Reactive nitrogen species contribute to innate host defense against Campylobacter jejuni. Infect Immun 2008, 76:986-993
58. Leib SL, Kim YS, Black SM, Tureen JH, Täuber MG: Inducible nitric oxide synthase and the effect of aminoguanidine in experimental neonatal meningitis. J Infect Dis 1998, 177:692-700
59. Lipton SA, Choi YB, Pan ZH, Lei SZ, Chen HS, Sucher NJ, Loscalzo J, Singel DJ, Stamler JS: A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 1993, 364:626-632
60. Waage A, Halstensen A, Shalaby R, Brandtzaeg P, Kierulf P, Espevik T: Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response. J Exp Med 1989, 170:1859-1867
61. Mustafa MM, Lebel MH, Ramilo O, Olsen KD, Reisch JS, Beutler B, McCracken GH Jr: Correlation of interleukin-1 beta and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis. J Pediatr 1989, 115:208-213
62. Hackett SJ, Thomson AP, Hart CA: Cytokines, chemokines and other effector molecules involved in meningococcal disease. J Med Microbiol 2001, 50:847-859
63. Alam MS, Akaike T, Okamoto S, Kubota T, Yoshitake J, Sawa T, Miyamoto Y, Tamura F, Maeda H: Role of nitric oxide in host defense in murine salmonellosis as a function of its antibacterial and antiapoptotic activities. Infect Immun 2002, 70:3130-3142
64. Nakashima K, Tomioka J, Kato S, Nishihara T, Kowashi Y: Nitric oxide-mediated protection of A. actinomycetemcomitans-infected murine macrophages against apoptosis. Nitric Oxide 2002, 6:61-68
65. Gobert AP, Cheng Y, Wang JY, Boucher JL, Iyer RK, Cederbaum SD, Casero RA Jr., Newton JC, Wilson KT: Helicobacter pylori induces macrophage apoptosis by activation of arginase II. J Immunol 2002, 168:4692-4700
66. Chan ED, Chan J, Schluger NW: What is the role of nitric oxide in murine and human host defense against tuberculosis? Current knowledge. Am J Respir Cell Mol Biol 2001, 25:606-612
67. Sukumaran SK, Selvaraj SK, Prasadarao NV: Inhibition of apoptosis by Escherichia coli K1 is accompanied by increased expression of BclXL and blockade of mitochondrial cytochrome c release in macrophages. Infect Immun 2004, 72:6012-6022
68. Rubin LL, Staddon JM: The cell biology of the blood-brain barrier. Annu Rev Neurosci 1999, 22:11-28
69. Hunter M, Wang Y, Eubank T, Baran C, Nana-Sinkam P, Marsh C: Survival of monocytes and macrophages and their role in health and disease. Front Biosci 2009, 14:4079-4102
70. Underhill DM, Ozinsky A: Phagocytosis of microbes: complexity in action. Annu Rev Immunol 2002, 20:825-852
71. Taylor PR, Martinez-Pomares L, Stacey M, Lin HH, Brown GD, Gordon S: Macrophage receptors and immune recognition. Annu Rev Immunol 2005, 23:901-944
72. Drevets DA, Leenen PJ, Campbell PA: Complement receptor type 3 (CD11b/CD18) involvement is essential for killing of Listeria monocytogenes by mouse macrophages. J Immunol 1993, 151:5431-5439
73. Drevets DA, Leenen PJ, Campbell PA: Complement receptor type 3 mediates phagocytosis and killing of Listeria monocytogenes by a TNF-alpha- and IFN-gamma-stimulated macrophage precursor hybrid. Cell Immunol 1996, 169:1-6
74. Gafa V, Manches O, Pastor A, Drouet E, Ambroise-Thomas P, Grillot R, Aldebert D: Human cytomegalovirus downregulates complement receptors (CR3. CR4) and decreases phagocytosis by macrophages J Med Virol 2005, 76:361-366
75. Watanabe I, Ichiki M, Shiratsuchi A, Nakanishi Y: TLR2-mediated survival of Staphylococcus aureus in macrophages: a novel bacterial strategy against host innate immunity. J Immunol 2007, 178:4917-4925
76. Higgins SC, Jarnicki AG, Lavelle EC, Mills KH: TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells.J Immunol 2006, 177:7980-7989
77. Weiss DJ, Souza CD, Evanson OA, Sanders M, Rutherford M: Bovine monocyte TLR2 receptors differentially regulate the intracellular fate of Mycobacterium avium subsp. paratuberculosis and Mycobacterium avium subsp. avium. J Leukoc Biol 2008, 83:48-55
78. Grage-Griebenow E, Flad HD, Ernst M, Bzowska M, Skrzeczyñska J, Pryjma J: Human MO subsets as defined by expression of CD64 and CD16 differ in phagocytic activity and generation of oxygen intermediates. Immunobiology 2000, 202:42-50
79. Ioan-Facsinay A, de Kimpe SJ, Hellwig SM, van Lent PL, Hofhuis FM, van Ojik HH, Sedlik C, da Silveira SA, Gerber J, de Jong YF, Roozendaal R, Aarden LA, van den Berg WB, Saito T, Mosser D, Amigorena S, Izui S, van Ommen GJ, van Vugt M, van de Winkel JG, Verbeek JS: FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity 2002, 16:391-402
80. Gonzalez-Mejia ME, Doseff AI: Regulation of monocytes and macrophages cell fate. Front Biosci 2009, 14:2413-2431
81. Mosser DM: Receptors on phagocytic cells involved in microbial recognition. Immunol Ser 1994, 60:99-114